The effect of limited healthcare access on poor outcomes among hospitalized COVID-19 patients in Honduras: A single center cohort study
César Alas-Pineda,
David Aguilar-Andino,
Francisco Antonio Vallecillo Munguia,
Gissela María Padilla David,
Andrea N. Umaña,
Luis Romero Reyes,
Alejandro Cárcamo,
Ana Liliam Osorio,
Julio Zuniga-Moya,
Eleazar Montalvan-Sanchez,
Travis J. Atchley,
Nicholas Michael Berry Laskay,
Dagoberto Estevez-Ordonez,
Orlando Garner,
Dalton Argean Norwood
Affiliations
César Alas-Pineda
Facultad de Medicina y Cirugía, Universidad Católica de Honduras – Campus San Pedro y San Pablo, San Pedro Sula, Cortés, Honduras; Departamento de Epidemiología, Hospital Nacional Dr. Mario Catarino Rivas, San Pedro Sula, Honduras
David Aguilar-Andino
Escuela Universitaria de Ciencias de la Salud, Universidad Nacional Autónoma de Honduras en el Valle de Sula, San Pedro Sula, Honduras; Departamento de Epidemiología, Hospital Nacional Dr. Mario Catarino Rivas, San Pedro Sula, Honduras
Francisco Antonio Vallecillo Munguia
Hospital Nacional Dr. Mario Catarino Rivas, San Pedro Sula, Honduras
Gissela María Padilla David
Hospital Nacional Dr. Mario Catarino Rivas, San Pedro Sula, Honduras
Andrea N. Umaña
Facultad de Medicina y Cirugía, Universidad Católica de Honduras – Campus San Pedro y San Pablo, San Pedro Sula, Cortés, Honduras
Luis Romero Reyes
Hospital Nacional Dr. Mario Catarino Rivas, San Pedro Sula, Honduras
Alejandro Cárcamo
Hospital Nacional Dr. Mario Catarino Rivas, San Pedro Sula, Honduras
Ana Liliam Osorio
Hospital Nacional Dr. Mario Catarino Rivas, San Pedro Sula, Honduras
Julio Zuniga-Moya
Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA
Eleazar Montalvan-Sanchez
Department of Medicine, School of Medicine, Indiana University, IN, USA
Travis J. Atchley
Department of Neurosurgery, School of Medicine, University of Birmingham at Alabama, AL, USA
Nicholas Michael Berry Laskay
Department of Neurosurgery, School of Medicine, University of Birmingham at Alabama, AL, USA
Dagoberto Estevez-Ordonez
Department of Neurosurgery, School of Medicine, University of Birmingham at Alabama, AL, USA
Orlando Garner
Clinical Assistant Professor, Department of Internal Medicine, Texas Tech University Health Sciences Center at the Permian Basin, TX, USA
Dalton Argean Norwood
Escuela Universitaria de Ciencias de la Salud, Universidad Nacional Autónoma de Honduras en el Valle de Sula, San Pedro Sula, Honduras; Division of Preventive Medicine, School of Medicine, University of Birmingham at Alabama, AL, USA; Minority Health & Health Equity Research Center, University of Birmingham at Alabama, AL, USA; Corresponding author. Division of Preventive Medicine, School of Medicine, University of Birmingham at Alabama, USA.
Background: The COVID-19 pandemic has had a severe impact on the Latin American subcontinent, particularly in areas with limited hospital resources and a restricted Intensive Care Unit (ICU) capacity. This study aimed to provide a comprehensive description of the clinical characteristics, outcomes, and factors associated with survival of COVID-19 hospitalized patients in Honduras. Research question: What were the characteristics and outcomes of COVID-19 patients in a large referral center in Honduras? Study design and methods: This study employed a retrospective cohort design conducted in a single center in San Pedro Sula, Honduras, between October 2020 to March 2021. All hospitalized cases of confirmed COVID-19 during this timeframe were included in the analysis. Univariable and multivariable survival analysis were performed using Kaplan-Meier curves and Cox proportional hazards model aiming to identify factors associated with decreased 30 day in-hospital survival, using a priori-selected factors. Results: A total of 929 confirmed cases were identified in this cohort, with males accounting for 55.4 % of cases. The case fatality rate among the hospitalized patients was found to be 50.1 % corresponding to 466 deaths. Patients with comorbidities such as hypertension, diabetes, obesity, chronic kidney disease, chronic obstructive pulmonary disease and cardiovascular disease had a higher likelihood of mortality. Additionally, non-survivors had a significantly longer time from illness onset to hospital admission compared to survivors (8.2 days vs 4.7 days). Among the cohort, 306 patients (32.9 %) met criteria for ICU admission. However, due to limited capacity, only 60 patients (19·6 %) were admitted to the ICU. Importantly, patients that were unable to receive level-appropriate care had lower likelihood of survival compared to those who received level-appropriate care (hazard ratio: 1.84). Interpretation: This study represents, the largest investigation of in-hospital COVID-19 cases in Honduras and Central America. The findings highlight a substantial case fatality rate among hospitalized patients. In this study, patients who couldn't receive level-appropriate care (ICU admission) had a significantly lower likelihood of survival when compared to those who did. These results underscore the significant impact of healthcare access during the pandemic, particularly in low- and middle-income countries.